Spirea Limited
Spirea Limited, a Cambridge-based startup working to develop a new generation of antibody-drug conjugate (ADC) treatments
Cambridge, UKwww.spirea.co.uk ↗
Total raised
€2.8M
€2,764,372
Funding rounds
1
Investors
0
distinct backers
Active since
2022-06
latest 2022-06
Funding by year
EUR raised per yearSignals
Medium confidenceRaise-next likelihood12
base rate 30% for Other
- ▼ Dormant (no round in 3+ cohort gaps)
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2022-06-14 | Other | €2.8M | — | View deal → |
Related news
- Female-led British biotech raises £2.4M to develop ‘smart bomb’ like drugs to kill cancer cells techfundingnews.com · 2022-06